Eisai Competitors and Similar CompaniesClear all

Eisai's competitors and similar companies include Nipro, Royal Bahrain Hospital, Agios Pharmaceuticals and Pharmstandard.
Eisai
Eisai
Eisai (エーザイ株式会社) is a research-based human healthcare company that discovers, develops, packages, and markets pharmaceutical products.
Nipro
Nipro
Nipro Corporation (ニプロ株式会社) is a company that has expertise in medical devices, pharmaceuticals, pharma packaging, and regenerative medicine business.
Royal Bahrain Hospital
Royal Bahrain Hospital
Royal Bahrain Hospital is a healthcare services provider.
Agios Pharmaceuticals
Agios Pharmaceuticals
Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.
Pharmstandard
Pharmstandard
Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products.
Founding Date
Founding Date
1941
Founding Date
1954
Founding Date
2011
Founding Date
2008
Founding Date
2003
Type
Type
Public
Type
Public
Type
Private
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Tokyo, JP HQ
Melbourne, AU
Wien, AT
Leuven, BE
Mississauga, CA
see more
Locations
Settsu, JP HQ
Sydney, AU
Vienna, AT
Dhaka, BD
Dhaka, BD
Dhaka, BD
Mechelen, BE
see more
Locations
Manama, BH HQ
Manama, BH
Locations
Cambridge, US HQ
Locations
Dolgoprudny, RU HQ
Kursk, RU
Moscow, RU
Petrovo Dalnee, RU
Tomsk, RU
Ufa, RU
Vol'ginskii, RU
Employees
Employees
11,067
Employees
38,117
Employees
324
Employees
53611% increase
Employees
1,77814% increase
Valuation ($)
Valuation ($)
9.6 b
Valuation ($)
1.5 b
Valuation ($)
N/A
Valuation ($)
2.7 b
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
¥789.4b (FY, 2025)
Revenue (est.)
¥644.6b (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
$54m (FY, 2025)
Revenue (est.)
₽152.1b (FY, 2024)
Cost of goods
Cost of goods
¥128.9b (FY, 2025)
Cost of goods
¥385.3b (FY, 2025)
Cost of goods
N/A
Cost of goods
$6.3m (FY, 2025)
Cost of goods
₽117b (FY, 2024)
Gross profit
Gross profit
¥677.7b (FY, 2025)
Gross profit
¥259.3b (FY, 2025)
Gross profit
N/A
Gross profit
$47.7m (FY, 2025)
Gross profit
₽35.2b (FY, 2024)
Net income
Net income
¥48.1b (FY, 2025)
Net income
¥6.7b (FY, 2025)
Net income
N/A
Net income
($412.8m) (FY, 2025)
Net income
₽22.7b (FY, 2024)
For sources of this data, please see the company profile

View Company Profiles

Nipro
HQ
Settsu, JP
Employees
38,117

Nipro Corporation (ニプロ株式会社) is a company that has expertise in medical devices, pharmaceuticals, pharma packaging, and regenerative medicine business.

View company
Royal Bahrain Hospital
HQ
Manama, BH
Employees
324

Royal Bahrain Hospital is a healthcare services provider.

View company
Agios Pharmaceuticals
HQ
Cambridge, US
Employees
536↑ 11% increase

Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.

View company
Pharmstandard
HQ
Dolgoprudny, RU

Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products.

View company